title: Osteonecrosis of the jaws in newly diagnosed multiple myeloma patients treated with zoledronic acid and thalidomide-dexamethasone.
authors.forename: Patrizia
authors.initials: P
authors.lastname: Tosi
authors.forename: Elena
authors.initials: E
authors.lastname: Zamagni
authors.forename: Delia
authors.initials: D
authors.lastname: Cangini
authors.forename: Paola
authors.initials: P
authors.lastname: Tacchetti
authors.forename: Francesco
authors.initials: F
authors.lastname: Di Raimondo
authors.forename: Lucio
authors.initials: L
authors.lastname: Catalano
authors.forename: Alfonso
authors.initials: A
authors.lastname: D'Arco
authors.forename: Sonia
authors.initials: S
authors.lastname: Ronconi
authors.forename: Claudia
authors.initials: C
authors.lastname: Cellini
authors.forename: Massimo
authors.initials: M
authors.lastname: Offidani
authors.forename: Giulia
authors.initials: G
authors.lastname: Perrone
authors.forename: Michela
authors.initials: M
authors.lastname: Ceccolini
authors.forename: Annamaria
authors.initials: A
authors.lastname: Brioli
authors.forename: Sante
authors.initials: S
authors.lastname: Tura
authors.forename: Michele
authors.initials: M
authors.lastname: Baccarani
authors.forename: Michele
authors.initials: M
authors.lastname: Cavo
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects*; D050071:Bone Density Conservation Agents / Q000008:administration & dosage / Q000009:adverse effects*; D003907:Dexamethasone / Q000008:administration & dosage / Q000009:adverse effects; D004164:Diphosphonates / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage / Q000009:adverse effects*; D007571:Jaw Diseases / Q000139:chemically induced* / Q000209:etiology; D008297:Male; D009101:Multiple Myeloma / Q000150:complications* / Q000188:drug therapy; D010020:Osteonecrosis / Q000139:chemically induced* / Q000209:etiology; D012189:Retrospective Studies; D013792:Thalidomide / Q000008:administration & dosage / Q000009:adverse effects; D000077211:Zoledronic Acid
chemical_list: D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D007093:Imidazoles; D013792:Thalidomide; D000077211:Zoledronic Acid; D003907:Dexamethasone